Metastatic bone disease is explained by Mercadante (1997) as disease that develops when there is abnormal metabolism within the bone with increased osteoclast activity. Patients with bone metastasis often present with pain, they are also at an increased risk of hypercalcaemia, fractures and in some cases metastatic spinal cord compression, all of which compromise the patient's functional status, quality of life, and survival. Clinicians should utilise the World Health Organization analgesic ladder (1986), alongside considering adjuvant therapies such as bisphosphonates and radiotherapy which are the mainstay of current treatment.
Radiotherapy is offered as a treatment to patients with localised bone pain, this is usually offered as local fixed
Radiotherapy is offered as a treatment to patients with localised bone pain, this is usually offered as local fixed